Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Eleva Capital SAS 13F Holdings -- Portfolio & Top Positions (2026-03-31)

Eleva Capital SAS (CIK 2054496) reported $343.4M across 24 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: CRH ($279.1M, 81.27%), AS ($9.8M, 2.86%), NVDA ($9.1M, 2.64%), NFLX ($8.4M, 2.44%), GOOGL ($8.0M, 2.34%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1CRHCRH PLC$279.1M81.27%2.7MTrimmed
2ASAMER SPORTS INC$9.8M2.86%298,802Added
3NVDANVIDIA CORPORATION$9.1M2.64%52,002New
4NFLXNETFLIX INC$8.4M2.44%87,190Added
5GOOGLALPHABET INC$8.0M2.34%27,967New
6TSMTAIWAN SEMICONDUCTOR MFG LT$6.5M1.89%21,411New
7ANETARISTA NETWORKS INC$5.8M1.68%46,957Added
8AMZNAMAZON COM INC$3.4M0.98%16,155New
9TMUST-MOBILE US INC$3.0M0.88%14,347New
10HOODROBINHOOD MKTS INC$2.2M0.64%31,625New
11ONONON HLDG AG$1.7M0.50%50,150New
12BSXBOSTON SCIENTIFIC CORP$1.7M0.49%26,667New
13SPOTSPOTIFY TECHNOLOGY S A$1.3M0.38%2,715New
14NAMSNEWAMSTERDAM PHARMA COMPANY$823,3290.24%25,721New
15CGONCG ONCOLOGY INC$561,0000.16%8,289New
16ESPRESPERION THERAPEUTICS INC$501,5490.15%183,047New
17MLYSMINERALYS THERAPEUTICS INC$462,7240.13%17,081New
18FENCFENNEC PHARMACEUTICALS INC$327,3890.10%53,234New
19IRONDISC MEDICINE INC$327,0530.10%5,115New
20FCXFREEPORT MCMORAN INC$132,7250.04%2,258New
21VRDNVIRIDIAN THERAPEUTICS INC$139,3850.04%7,126New
22ACHRARCHER AVIATION INC$111,3310.03%21,534New
23EWTXEDGEWISE THERAPEUTICS INC$54,9900.02%17,460New
24BMRNBIOMARIN PHARMACEUTICAL INC$00.00%0Exited
25COHRCOHERENT CORP$00.00%0Exited

Source: SEC Form 13F filings · as of 2026-03-31